Pharma industry reports 61 deals worth $6.4 billion in June 2022
The industry reported 115 Venture Capital (VC) deals worth $3.7 billion in June 2022, compared to the last 12-month average (June 2021 to May 2022) of 161 deals worth $4.3 billion. The pharma industry reported 61 deals worth $6.4 billion as compar...
See more